The overexpression of PD-L1 on tumor cells is induced by genetic alterations (innate expression) and stimulation by interferon gamma (IFN-γ) released from effector T cells, including CD8+ T cells (acquired expression) (13, 29). The gene discussed is IFNG; the disease is neoplasm.